Reticular dysgenesis in a preterm infant: a case report

Pediatr Hematol Oncol. 2010 Nov;27(8):646-9. doi: 10.3109/08880018.2010.509424.

Abstract

Reticular dysgenesis (RD) is a rare congenital immunodeficiency classified within the severe combined immunodeficiencies (SCIDs) and characterized by impairment of both lymphoid and myeloid cell development. Neutropenia unresponsive to recombinant human granulocyte colony-stimulating factor (rGCSF) is the hallmark of RD and the clinical course is rapidly fatal due to overwhelming infections. The authors report a female newborn at 32 weeks of gestation presenting with severe leukopenia at birth. The bone marrow showed a maturation arrest in the myeloid and lymphoid lineage. She had no response to granulocyte colony stimulating factor (rGCSF) treatment and died with sepsis at age of 2 months.

Publication types

  • Case Reports

MeSH terms

  • Bone Marrow Transplantation
  • Fatal Outcome
  • Female
  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Humans
  • Infant
  • Leukopenia* / diagnosis
  • Leukopenia* / therapy
  • Severe Combined Immunodeficiency* / diagnosis
  • Severe Combined Immunodeficiency* / therapy

Substances

  • Granulocyte Colony-Stimulating Factor

Supplementary concepts

  • Reticular dysgenesis